Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticoids

R P Kimberly1

  • 1Hospital for Special Surgery, Cornell University Medical College, New York, New York.

Current Opinion in Rheumatology
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Glucocorticoids are essential therapeutics despite ongoing risk-benefit debates. Research clarifies their gene effects and clinical applications, including impacts on multiple sclerosis and bone loss prevention with calcium and vitamin D.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.

Genes and immunity·2015
Same author

Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.

Genes and immunity·2014
Same author

GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.

Genes and immunity·2014
Same author

A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus.

Genes and immunity·2012
Same author

Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis.

Genes and immunity·2011
Same author

The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed.

Genes and immunity·2011
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Endocrinology and Pharmacology
  • Immunology
  • Reproductive Medicine

Background:

  • Glucocorticoids remain crucial in therapy despite risks.
  • Ongoing research explores their complex biological mechanisms, particularly gene transcription.
  • Clinical practice evolves with careful observation of their effects.

Purpose of the Study:

  • To summarize recent advancements in understanding glucocorticoid therapy.
  • To highlight key findings regarding their impact on specific diseases and conditions.
  • To underscore the importance of continued research into glucocorticoid's multifaceted roles.

Main Methods:

  • Review of current scientific literature and clinical observations.
  • Analysis of recent studies on glucocorticoid effects.

Related Experiment Videos

  • Synthesis of data on therapeutic applications and potential adverse effects.

    • Main Results:

    • High-dose intravenous methylprednisolone may influence multiple sclerosis development.
    • Prednisone shows limited efficacy in high-risk antiphospholipid antibody pregnancies.
    • Calcium and vitamin D supplementation can prevent steroid-induced bone loss.

    Conclusions:

    • Glucocorticoid therapy requires careful consideration of specific clinical contexts.
    • Further research is needed to optimize glucocorticoid use and mitigate risks.
    • Preventive strategies like calcium and vitamin D are vital for patients on long-term steroids.